Peter Heeringa Selected Research

Kidney Cortex Necrosis

7/2005	Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
10/2002	Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Heeringa Research Topics

Disease

34	Inflammation (Inflammations) 01/2022 - 06/2002
30	Vasculitis (Vasculitides) 12/2019 - 10/2002
25	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 01/2004
23	Glomerulonephritis 01/2022 - 03/2002
15	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020 - 10/2002
9	Atherosclerosis 01/2020 - 05/2002
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2007
6	Giant Cell Arteritis (Horton Disease) 01/2022 - 07/2018
6	Microscopic Polyangiitis 11/2018 - 10/2002
5	Infections 01/2022 - 12/2010
5	Fibrosis (Cirrhosis) 01/2022 - 06/2002
5	Sepsis (Septicemia) 12/2018 - 04/2010
5	Ischemia 03/2013 - 02/2003
4	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 10/2004
4	Systemic Vasculitis 01/2018 - 10/2004
4	Albuminuria 01/2017 - 03/2008
4	Reperfusion Injury 10/2004 - 02/2003
3	Obesity 01/2022 - 01/2016
3	Churg-Strauss Syndrome (Allergic Angiitis) 12/2013 - 07/2005
3	Nephritis 04/2013 - 07/2002
2	Insulin Resistance 01/2017 - 01/2012
2	Lupus Nephritis 09/2016 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 01/2012
2	Atherosclerotic Plaque (Atheroma) 11/2013 - 06/2002
2	Hemorrhagic Shock 07/2013 - 09/2011
2	Shock 09/2011 - 08/2009
2	Hemorrhage 12/2010 - 06/2002
2	Kidney Cortex Necrosis 07/2005 - 10/2002
1	Critical Illness (Critically Ill) 01/2022
1	Cicatrix (Scar) 01/2022
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	COVID-19 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Vascular Remodeling 10/2021
1	Aneurysm (Aneurysms) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Hyperplasia 01/2020
1	Proteinuria 01/2019
1	Kidney Neoplasms (Kidney Cancer) 12/2018

Drug/Important Bio-Agent (IBA)

38	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 10/2002
28	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2002
16	AutoantibodiesIBA 01/2021 - 10/2002
14	AntibodiesIBA 01/2022 - 01/2004
11	CytokinesIBA 10/2021 - 02/2004
11	Immunoglobulin G (IgG)IBA 11/2018 - 07/2002
10	Myeloblastin (Proteinase 3)IBA 01/2022 - 11/2005
9	LipopolysaccharidesIBA 01/2022 - 02/2003
7	Complement System Proteins (Complement)IBA 12/2018 - 02/2003
6	Proteins (Proteins, Gene)FDA Link 12/2019 - 12/2007
5	LipidsIBA 05/2015 - 05/2002
5	CholesterolIBA 05/2015 - 04/2010
5	E-SelectinIBA 01/2012 - 07/2007
4	AutoantigensIBA 01/2021 - 03/2011
4	Messenger RNA (mRNA)IBA 12/2018 - 08/2009
4	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2015 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
3	C-Reactive ProteinIBA 11/2021 - 01/2012
3	HMGB1 Protein (HMG1)IBA 12/2016 - 03/2013
3	Monoclonal AntibodiesIBA 09/2016 - 02/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2016 - 12/2010
3	Apolipoproteins E (ApoE)IBA 05/2015 - 03/2011
3	antiglomerular basement membrane antibodyIBA 01/2013 - 08/2005
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2012 - 03/2011
2	AdipokinesIBA 01/2022 - 01/2017
2	Pyruvate KinaseIBA 01/2022 - 01/2022
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2020
2	Angiopoietin-2IBA 01/2022 - 03/2013
2	EnzymesIBA 01/2022 - 10/2004
2	Peptide Hydrolases (Proteases)FDA Link 11/2021 - 01/2004
2	CreatinineIBA 01/2019 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018 - 09/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 09/2006
2	Immune Checkpoint InhibitorsIBA 01/2018 - 01/2018
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2016 - 08/2009
2	Anthocyanins (Anthocyanin)IBA 01/2016 - 05/2015
2	Catechin (Z 7300)IBA 01/2016 - 03/2014
2	EpitopesIBA 04/2013 - 03/2008
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012 - 09/2011
2	NF-kappa B (NF-kB)IBA 03/2011 - 02/2004
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 05/2009 - 02/2003
2	Pharmaceutical PreparationsIBA 03/2008 - 07/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2008 - 07/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006 - 07/2005
1	LeptinIBA 01/2022
1	Viral ProteinsIBA 01/2022
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 12/2021
1	AntigensIBA 11/2021
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2019
1	Complement Factor H (Factor H)IBA 12/2018
1	Alkylating AgentsIBA 11/2018
1	Histone Deacetylase InhibitorsIBA 11/2018

Therapy/Procedure

5	Therapeutics 11/2018 - 09/2006
2	Nephrectomy 12/2018 - 02/2003